e-Drug3D

126

cas 59-96-1

CLASS

CARDIOVASCULAR
ANTIHYPERTENSIVE
ADRENERGIC ALPHA ANTAGONISTS
VASODILATOR AGENTS
TREATMENT OF PHEOCHROMOCYTOMA
TREATMENT OF EPISODES OF HYPERTENSION

ROUTE (list)

ORAL

PK parameters

F 25 PERCENT
t1/2 24 HOUR

MW 303.82
NB_atoms 21
XLogP 4.19
PSA 10.952
NB_HD 0
NB_HA 2
fsp3 0.33
Lipinski(0=no;1=yes) 1

FDA
NDA 008708 (pdf not found) INN (PHENOXYBENZAMINE HYDROCHLORIDE) DIBENZYLINE (ADVANZ PHARMA) APPROVAL= AP YEAR= 1953
NDA 201050 (pdf not found) INN (PHENOXYBENZAMINE HYDROCHLORIDE) PHENOXYBENZAMINE HYDROCHLORIDE (HIKMA) APPROVAL= AP YEAR= 2012 DISCONTINUED
NDA 204522 (pdf not found) INN (PHENOXYBENZAMINE HYDROCHLORIDE) PHENOXYBENZAMINE HYDROCHLORIDE (PH HEALTH) APPROVAL= AP YEAR= 2017
NDA 212568 (pdf not found) INN (PHENOXYBENZAMINE HYDROCHLORIDE) PHENOXYBENZAMINE HYDROCHLORIDE (AMNEAL) APPROVAL= AP YEAR= 2020
NDA 215042 (pdf not found) INN (PHENOXYBENZAMINE HYDROCHLORIDE) PHENOXYBENZAMINE HYDROCHLORIDE (NOVITIUM PHARMA) APPROVAL= AP YEAR= 2022
NDA 204551 (pdf not found) INN (PHENOXYBENZAMINE HYDROCHLORIDE) PHENOXYBENZAMINE HYDROCHLORIDE (RISING) APPROVAL= AP YEAR= 2023
NDA 215600 (pdf not found) INN (PHENOXYBENZAMINE HYDROCHLORIDE) PHENOXYBENZAMINE HYDROCHLORIDE (AUROBINDO PHARMA) APPROVAL= AP YEAR= 2023